本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Protagonist Therapeutics Inc

42.97
-0.9500-2.16%
盤後42.970.00000.00%16:08 EDT
成交量:67.12萬
成交額:2,931.35萬
市值:26.63億
市盈率:49.82
高:45.43
開:44.15
低:42.85
收:43.92
資料載入中...
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/16

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/20

重要事件披露

Form 8-K - Current report
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans